China’s Hua Medicine mulls Hong Kong IPO as diabetes drug enters crucial clinical trial phase

Life Science

Ping An Signs Strategic Oncology Partnership MOU with Varian

Life Science

WuXi AppTec Forms Clinical Testing JV with the Mayo Clinic

Life Science

Life Science & Technology Weekly 127 – Dental 3D printing market to reach $9.5 billion by 2027

Life Science, Technology

Shanghai Fosun Forms $50 Million US JV — With Itself

Life Science

Chinese Caution on U.S. Debt Clouds Financing for Trump’s Tax Cut

Life Science, Precious Metals

BeiGene And Mirati Therapeutics Announce Exclusive License Agreement For Sitravatinib In The Asia Pacific Region

Life Science

BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement for Anti-PD-1 Antibody Tislelizumab

Life Science

China News Weekly 44 – Zhejiang DTRM Completes $60 Million A Round for US-China Clinical Trials

Life Science, Technology

Simcere Acquires China Rights to Three Bi-Specific Immunoncology Drugs

Life Science

Zhejiang DTRM Completes $60 Million A Round for US-China Clinical Trials

Life Science

Jiangsu Hengrui Out-Licenses Novel Dermatology Drug for $233 Million

Life Science

Miracor Closes $30 Million D Round, Led by Shenzhen’s Ming Capital

Life Science

Genostics Invests $13.5 Million in UK’s Oncimmune for China Rights to Lung Cancer Test

Life Science

Illumina Collaborates with KingMed on China Oncology IVD Assays

Life Science